Bidda Rolin

3.0k citations

47 papers · 2.4k indexed · 1 hit paper · h-index 25

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Treatment and Management
- Diabetes Management and Research
Endocrine and Autonomic Systems top 5%

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 27
- Diabetes Treatment and Management 15
- Diabetes Management and Research 10
Surgery 24
- Pancreatic function and diabetes 19

Co-authors: Marianne O. Larsen (17 shared papers)Lotte Bjerre Knudsen (9 shared papers)C. F. Gotfredsen (12 shared papers)Michael Wilken (15 shared papers)Richard D. Carr (8 shared papers)Carolyn F. Deacon (5 shared papers)Christian L. Brand (3 shared papers)Günaj Rakipovski (4 shared papers)
Journals: Diabetologia (5 papers)American Journal of Physiology-Endocrinology and Metabolism (4 papers)PLoS ONE (4 papers)Scientific Reports (3 papers)Diabetes (3 papers)
Partner nations: Denmark United States United Kingdom

In The Last Decade

Bidda Rolin

46 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways 2018 · 350 citations

Peers

Countries citing papers authored by Bidda Rolin

Since Specialization

Citations

This map shows the geographic impact of Bidda Rolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bidda Rolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bidda Rolin more than expected).

Fields of papers citing papers by Bidda Rolin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bidda Rolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bidda Rolin. The network helps show where Bidda Rolin may publish in the future.

Co-authors

The 25 scholars most cited alongside Bidda Rolin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bidda Rolin Line = papers co-authored together Bidda Rolin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways JACC Basic to Translational Science ·Günaj Rakipovski, Bidda Rolin, Jane Nøhr, Ib Vestergaard Klewe, Klaus Stensgaard Frederiksen, Robert Augustin, Jacob Hecksher‐Sørensen, Camilla Ingvorsen, Joseph Polex-Wolf, Lotte Bjerre Knudsen Hit paper breakdown →	2018	350
2	The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice American Journal of Physiology-Endocrinology and Metabolism ·Bidda Rolin, Marianne O. Larsen, C. F. Gotfredsen, Carolyn F. Deacon, Richard D. Carr, Michael Wilken, Lotte Bjerre Knudsen	2002	251
3	Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes ·Jannie Fuhlendorff, Patrik Rorsman, Hans Kofod, Christian L. Brand, Bidda Rolin, P. Mackay, Ronald M. Shymko, Richard D. Carr	1998	249
4	Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not Diabetes ·Kirsten Raun, Pia von Voss, C. F. Gotfredsen, Valeria Golozoubova, Bidda Rolin, Lotte Bjerre Knudsen	2006	181
5	GLP‐1 derivative liraglutide in rats with β‐cell deficiencies: influence of metabolic state on β‐cell mass dynamics British Journal of Pharmacology ·Jeppe Sturis, C. F. Gotfredsen, John Rømer, Bidda Rolin, Ulla Ribel, Christian L. Brand, Michael Wilken, Karsten Wassermann, Carolyn F. Deacon, Richard D. Carr, Lotte Bjerre Knudsen	2003	176
6	Use of the Gottingen Minipig as a Model of Diabetes, with Special Focus on Type 1 Diabetes Research ILAR Journal ·Marianne O. Larsen, Bidda Rolin	2004	161
7	Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats Diabetologia ·Christian L. Brand, Bidda Rolin, Peer Nobert J�rgensen, I. Svendsen, J. S. Kristensen, Jens J. Holst	1994	115
8	Mild streptozotocin diabetes in the Göttingen minipig. A novel model of moderate insulin deficiency and diabetes American Journal of Physiology-Endocrinology and Metabolism ·Marianne O. Larsen, Michael Wilken, C. F. Gotfredsen, Richard D. Carr, Ove Svendsen, Bidda Rolin	2002	89
9	NN2211: a long-acting glucagon-like peptide-1 derivative with anti-diabetic effects in glucose-intolerant pigs European Journal of Pharmacology ·Ulla Ribel, Marianne O. Larsen, Bidda Rolin, Richard D. Carr, Michael Wilken, Jeppe Sturis, Lisbet Westergaard, Carolyn F. Deacon, Lotte Bjerre Knudsen	2002	67
10	Measurements of Insulin Secretory Capacity and Glucose Tolerance to Predict Pancreatic β-Cell Mass In Vivo in the Nicotinamide/Streptozotocin Gottingen Minipig, a Model of Moderate Insulin Deficiency and Diabetes Diabetes ·Marianne O. Larsen, Bidda Rolin, Michael Wilken, Richard D. Carr, C. F. Gotfredsen	2003	53
11	Chamber-Dependent Expression of Brain Natriuretic Peptide and Its mRNA in Normal and Diabetic Pig Heart Hypertension ·Christina Christoffersen, Jens P. Goetze, Emil D. Bartels, Marianne O. Larsen, Ulla Ribel, Jens F. Rehfeld, Bidda Rolin, Lars B. Nielsen	2002	45
12	Liraglutide Decreases Hepatic Inflammation and Injury in Advanced Lean Non‐Alcoholic Steatohepatitis Basic & Clinical Pharmacology & Toxicology ·David Højland Ipsen, Bidda Rolin, Günaj Rakipovski, Gry Freja Skovsted, Anette Madsen, Stefanie Kolstrup, Anne Marie V. Schou‐Pedersen, Josephine Skat‐Rørdam, Jens Lykkesfeldt, Pernille Tveden‐Nyborg	2018	45
13	High‐Fat High‐Energy Feeding Impairs Fasting Glucose and Increases Fasting Insulin Levels in the Göttingen Minipig Annals of the New York Academy of Sciences ·Marianne O. Larsen, Bidda Rolin, Michael Wilken, Richard D. Carr, Ove Svendsen	2002	44
14	Modulating the Gut Microbiota Improves Glucose Tolerance, Lipoprotein Profile and Atherosclerotic Plaque Development in ApoE-Deficient Mice PLoS ONE ·Ida Rune, Bidda Rolin, Christian S. Larsen, Dennis Sandris Nielsen, Jenny E. Kanter, Karin Bornfeldt, Jens Lykkesfeldt, Karsten Buschard, Rikke Kaae Kirk, Berit Østergaard Christoffersen, Johannes Josef Fels, Knud Josefsen, Pernille Kihl, Axel Kornerup Hansen	2016	43
15	The major glucagon-like peptide-1 metabolite, GLP-1-(9–36)-amide, does not affect glucose or insulin levels in mice European Journal of Pharmacology ·Bidda Rolin, Carolyn F. Deacon, Richard D. Carr, Bo Åhrén	2004	33
16	Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice PLoS ONE ·Line S. Bisgaard, Markus H. Bosteen, Lisbeth N. Fink, Charlotte Mehlin Sørensen, Alexander Rosendahl, Christina Mogensen, Salka E. Rasmussen, Bidda Rolin, Lars B. Nielsen, T. Pedersen	2016	32
17	Measurements of insulin responses as predictive markers of pancreatic β-cell mass in normal and β-cell-reduced lean and obese Göttingen minipigs in vivo American Journal of Physiology-Endocrinology and Metabolism ·Marianne O. Larsen, Bidda Rolin, Jeppe Sturis, Michael Wilken, Richard D. Carr, Niels Pörksen, C. F. Gotfredsen	2005	32
18	Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats Metabolism ·Peter Oturai, Mogens Christensen, Bidda Rolin, Kent Pedersen, Steen B. Mortensen, Esper Boel	2000	31
19	High-fat but not sucrose intake is essential for induction of dyslipidemia and non-alcoholic steatohepatitis in guinea pigs Nutrition & Metabolism ·David Højland Ipsen, Pernille Tveden‐Nyborg, Bidda Rolin, Günaj Rakipovski, Maria Beck, Line Winther Mortensen, Lasse Færk, Peter M. H. Heegaard, Peter Möller, Jens Lykkesfeldt	2016	30
20	β-Cell function and islet morphology in normal, obese, and obese β-cell mass-reduced Göttingen minipigs American Journal of Physiology-Endocrinology and Metabolism ·Marianne O. Larsen, Claus Bogh Juhl, Niels Pörksen, C. F. Gotfredsen, Richard D. Carr, Ulla Ribel, Michael Wilken, Bidda Rolin	2004	30

About Bidda Rolin

Bidda Rolin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Physiology and Genetics, having authored 47 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (19 papers), Diabetes Treatment and Management (15 papers), Diabetes Management and Research (10 papers), Metabolism, Diabetes, and Cancer (7 papers), Diabetes and associated disorders (6 papers), Diet and metabolism studies (5 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Adipose Tissue and Metabolism (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Endocrine and Autonomic Systems (156 citations), Surgery (1.0k citations), Pharmacology (237 citations) and Molecular Biology (920 citations). Bidda Rolin has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Marianne O. Larsen, Lotte Bjerre Knudsen, C. F. Gotfredsen, Michael Wilken, Richard D. Carr, Carolyn F. Deacon, Christian L. Brand, Günaj Rakipovski, Ulla Ribel and Klaus Stensgaard Frederiksen. Their work appears in journals such as Diabetologia, American Journal of Physiology-Endocrinology and Metabolism, PLoS ONE, Scientific Reports and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact